Your browser doesn't support javascript.
loading
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu, Yajing; Chen, Yangpeng; Guo, Huidong; Li, Mengke; Wang, Bichen; Shi, Deyang; Cheng, Xuelian; Guan, Jinxia; Wang, Xiaomin; Xue, Chenghai; Cheng, Tao; Shi, Jun; Yuan, Weiping.
Affiliation
  • Chu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China. chuyajing@ihcams.ac.cn.
  • Chen Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Guo H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Li M; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Diseases, Peking University People's Hospital, Peking University Institute of Hematology, 100044, Beijing, China.
  • Wang B; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Shi D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Cheng X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Guan J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Wang X; My Health Gene Technology Co., Ltd., Service Centre of Tianjin Chentang Science and Technology Commercial District, 300220, Tianjin, China.
  • Xue C; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Cheng T; My Health Gene Technology Co., Ltd., Service Centre of Tianjin Chentang Science and Technology Commercial District, 300220, Tianjin, China.
  • Shi J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China.
  • Yuan W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020, Tianjin, China. shijun@ihcams.ac.cn.
Oncogene ; 39(50): 7239-7252, 2020 12.
Article in En | MEDLINE | ID: mdl-33037410
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Repressor Proteins / Leukemia, Myeloid, Acute / Oncogene Proteins, Fusion / Disease Progression / Myeloid-Lymphoid Leukemia Protein / Methyltransferases Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncogene Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Repressor Proteins / Leukemia, Myeloid, Acute / Oncogene Proteins, Fusion / Disease Progression / Myeloid-Lymphoid Leukemia Protein / Methyltransferases Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncogene Year: 2020 Document type: Article